Barr E S & Co
- SEC CIK
- 0001040210
- Latest filing
- Aug 13, 2026
PFE holding history
Pfizer Inc in every 13F filed by Barr E S & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −23,524−100.0% | Sold out | Holders |
| Q4 2025 | 23,524 | $585.7K | <0.1% | +23,524 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −7,680−100.0% | Sold out | Holders |
| Q3 2024 | 7,680 | $222.3K | <0.1% | −1,088−12.4% | Reduced | Holders |
| Q2 2024 | 8,768 | $245.3K | <0.1% | −140−1.6% | Reduced | Holders |
| Q1 2024 | 8,908 | $247.2K | <0.1% | −945−9.6% | Reduced | Holders |
| Q4 2023 | 9,853 | $283.7K | <0.1% | +945+10.6% | Added | Holders |
| Q3 2023 | 8,908 | $295.5K | <0.1% | −100−1.1% | Reduced | Holders |
| Q2 2023 | 9,008 | $330.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 9,008 | $367.5K | <0.1% | −1,500−14.3% | Reduced | Holders |
| Q4 2022 | 10,508 | $538.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,508 | $460.0K | <0.1% | −506−4.6% | Reduced | Holders |
| Q2 2022 | 11,014 | $577.0K | <0.1% | −3,342−23.3% | Reduced | Holders |
| Q1 2022 | 14,356 | $743.0K | 0.1% | −1,000−6.5% | Reduced | Holders |
| Q4 2021 | 15,356 | $907.0K | 0.1% | −57−0.4% | Reduced | Holders |
| Q3 2021 | 15,413 | $663.0K | <0.1% | +57+0.4% | Added | Holders |
| Q2 2021 | 15,356 | $601.0K | <0.1% | +3,038+24.7% | Added | Holders |
| Q1 2021 | 12,318 | $446.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.